# Pentoxifylline on Inflammatory Markers in Non-Diabetic Chronic Kidney Disease Patients

> **NCT07315139** · NA · COMPLETED · sponsor: **Ain Shams University** · enrollment: 42 (actual)

## Conditions studied

- Pentoxifylline
- Inflammatory Markers
- Non-Diabetic
- Chronic Kidney Disease

## Interventions

- **DRUG:** Angiotensin-converting enzyme inhibitors (Ramipril)
- **DRUG:** Pentoxifylline

## Key facts

- **NCT ID:** NCT07315139
- **Lead sponsor:** Ain Shams University
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2023-02-01
- **Primary completion:** 2023-08-31
- **Final completion:** 2023-08-31
- **Target enrollment:** 42 (ACTUAL)
- **Last updated:** 2026-01-02


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07315139

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07315139, "Pentoxifylline on Inflammatory Markers in Non-Diabetic Chronic Kidney Disease Patients". Retrieved via AI Analytics 2026-06-16 from https://api.ai-analytics.org/clinical/NCT07315139. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*